Orion Pharma and Orion Infusion, two listed concerns Orion Group, posted contrasting financial results for the fiscal year that ended on June 30, 2024.
Orion Infusion has decided to give 20 per cent cash dividend to its investors for 2021-22.
Investor Abu Sayeed was eagerly buying stocks of Orion Infusion sitting inside a brokerage house in Dhaka last Thursday. The share of the company had almost tripled in the past three months.
Orion Pharma and Orion Infusion, two listed concerns Orion Group, posted contrasting financial results for the fiscal year that ended on June 30, 2024.
Orion Infusion has decided to give 20 per cent cash dividend to its investors for 2021-22.
Investor Abu Sayeed was eagerly buying stocks of Orion Infusion sitting inside a brokerage house in Dhaka last Thursday. The share of the company had almost tripled in the past three months.
